Jefferies analyst Surinder Thind maintained a Sell rating on Envestnet (ENV – Research Report) today and set a price target of $47.00.
Surinder Thind has assigned a Sell rating to Envestnet’s stock based on a series of concerns, primarily revolving around the unexpected early departure of CEO Bill Crager. The timing of this change is particularly alarming due to it occurring 1-2 years sooner than what was anticipated by the market and industry observers. This suggests a potential uncertainty in the company’s leadership and direction, which could impact investor confidence and the firm’s strategic execution.
The recent years have seen Envestnet heavily investing in efforts to stimulate organic growth, yet these initiatives have not yielded the desired results. The forthcoming change in CEO, following a recent appointment of a new CFO, signals a possible significant strategic pivot away from a focus on top-line growth. Such a shift could introduce additional risks and challenges, thus contributing to the rationale behind the Sell recommendation for Envestnet’s stock.
See Insiders’ Hot Stocks on TipRanks >>
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Envestnet (ENV) Company Description:
Envestnet, Inc. engages in the provision of intelligent systems for wealth management and financial wellness. It operates through the Envestnet and Envestnet/Yodlee business segments. The Envestnet segment provides wealth management software and services to empower financial advisors and institutions. The Envestnet/ Yodlee segment offers a data aggregation and data intelligence platform for digital financial services. The company was founded by Judson Taft Bergman, James Winfield Lumberg and Brandon Rockwell Thomas in 1999 and is headquartered in Chicago, IL.
Read More on ENV:
- Envestnet price target raised to $70 from $66 at DA Davidson
- Envestnet exploring sale of Yodlee, Bloomberg reports
- Envestnet identifies compounds from EVM301 Series for preclinical development
- Envestnet price target lowered to $76 from $78 at JMP Securities
- Envestnet price target lowered to $47 from $67 at RBC Capital
